Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001678670-16-000001
Filing Date
2016-07-01
Accepted
2016-07-01 10:00:06
Documents
1
Effectiveness Date
2016-07-01
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5486
  Complete submission text file 0001678670-16-000001.txt   6528
Mailing Address 4225 EXECUTIVE SQUARE, SUITE 495 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE, SUITE 495 SAN DIEGO CA 92037 949-351-0860
DNX Biopharmaceuticals (Filer) CIK: 0001678670 (see all company filings)

EIN.: 472517263 | State of Incorp.: CA | Fiscal Year End: 1230
Type: D | Act: 33 | File No.: 021-266229 | Film No.: 161745084